| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 2,875,877 | 2,914,929 | 3,281,448 | 3,439,877 | | Cost of Revenue | 423,873 | 503,926 | 545,898 | 579,829 | | | Gross Profit | 2,452,004 | 2,411,003 | 2,735,550 | 2,860,048 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,410,311 | 1,807,547 | 1,419,435 | 1,302,075 | | Non Recurring |
-
| (236,168) | 230,100 | 11,723 | | Others | 1,761,114 | 1,191,582 | 501,135 | 473,264 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (719,421) | (351,958) | 584,880 | 1,072,986 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (719,421) | (351,958) | 584,880 | 1,072,986 | | Interest Expense | 243,364 | 304,585 | 325,203 | 329,820 | | Income Before Tax | (962,785) | (656,543) | 259,677 | 743,166 | | Income Tax Expense | (150,777) | (308,956) | (52,767) | 202,804 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (812,008) | (347,587) | 312,444 | 540,362 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (812,008) | (347,587) | 312,444 | 540,362 | | Preferred Stock And Other Adjustments | (63,373) | (31,634) | (5,111) | (5,112) | | | Net Income Applicable To Common Shares | ($875,381) | ($379,221) | $307,333 | $535,250 |
|
0.45% Nasdaq 
0.20%
Income Statement
